No Prescription |
 |
 | ||
|
Thyronorm Levothroid |
|
| ||
No Prescription » Prescription Drugs 16 » Thyronorm Levothroid Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces the hormone that is normally produced by the thyroid gland. Low thyroid levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. It is important to have adequate levels of thyroid hormone in your bloodstream to maintain normal mental and physical activity. In children adequate levels of thyroid hormone are important for normal mental and physical growth and development.This medication is used to treat other types of thyroid disorders as well (e.g. certain types of goiters thyroid nodules thyroiditis thyroid cancer). Buy Thyronorm Levothroid and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About Thyronorm Levothroid: Product Type: Prescription Drugs 16 Thyronorm ( Levothroid Levoxyl Synthroid Unithroid Generic Levothyroxine ) Thyronorm (Levothroid Levoxyl Synthroid Unithroid Generic Levothyroxine) Levothroid Levoxyl Synthroid Unithroid Generic Levothyroxine 125mcg 400(4 x 100 Tablets) 125mcg 100 Tablets 125mcg 200(2 x 100 Tablets) 25mcg 100 Tablets 25mcg 200(2 x 100 Tablets) 25mcg 400(4 x 100 Tablets) 75mcg 200(2 x 100 Tablets) 75mcg 400(4 x 100 Tablets) 75mcg 100 Tablets Levothroid Levoxyl Synthroid Unithroid Generic Levothyroxine Thyronorm
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
